1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Glioblastoma Multiforme Treatment (GBM) Market
2.2. Global Glioblastoma Multiforme Treatment (GBM) Market, By Treatment, 2024 (US$ Million)
2.3. Global Glioblastoma Multiforme Treatment (GBM) Market, By End-user, 2024 (US$ Million)
2.4. Global Glioblastoma Multiforme Treatment (GBM) Market, By Geography, 2024 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2024

3. Glioblastoma Multiforme Treatment (GBM) Market: Competitive Analysis
3.1. Market Positioning of Key Glioblastoma Multiforme Treatment (GBM) Market Vendors
3.2. Strategies Adopted by Glioblastoma Multiforme Treatment (GBM) Market Vendors

4. Glioblastoma Multiforme Treatment (GBM) Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Glioblastoma Multiforme Treatment (GBM) Market Value, 2023 - 2033, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Technology Landscape
4.6.4. Legal Landscape
4.6.5. Social Landscape

5. Glioblastoma Multiforme Treatment (GBM) Market: By Treatment, 2023-2033, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2024 Versus 2033
5.3. Market Segmentation
5.3.1. Radiation Therapy
5.3.2. Chemotherapy
5.3.2.1. Temozolomide
5.3.2.2. Bevacizumab
5.3.2.3. Carmustine
5.3.2.4. Other Types of Chemotherapy
5.3.3. Other Treatments

6. Glioblastoma Multiforme Treatment (GBM) Market: By End-user, 2023-2033, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2024 Versus 2033
6.3. Market Segmentation
6.3.1. Hospitals
6.3.2. Ambulatory Surgical Centers
6.3.3. Clinics


7. North America Glioblastoma Multiforme Treatment (GBM) Market, 2023-2033, USD (Million)
7.1. Market Overview
7.2. Glioblastoma Multiforme Treatment (GBM) Market: By Treatment, 2023-2033, USD (Million)
7.3. Glioblastoma Multiforme Treatment (GBM) Market: By End-user, 2023-2033, USD (Million)
7.4.Glioblastoma Multiforme Treatment (GBM) Market: By Region, 2023-2033, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Glioblastoma Multiforme Treatment (GBM) Market: By Treatment, 2023-2033, USD (Million)
7.4.1.1.2. Glioblastoma Multiforme Treatment (GBM) Market: By End-user, 2023-2033, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Glioblastoma Multiforme Treatment (GBM) Market: By Treatment, 2023-2033, USD (Million)
7.4.1.2.2. Glioblastoma Multiforme Treatment (GBM) Market: By End-user, 2023-2033, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Glioblastoma Multiforme Treatment (GBM) Market: By Treatment, 2023-2033, USD (Million)
7.4.1.3.2. Glioblastoma Multiforme Treatment (GBM) Market: By End-user, 2023-2033, USD (Million)

8. UK and European Union Glioblastoma Multiforme Treatment (GBM) Market, 2023-2033, USD (Million)
8.1. Market Overview
8.2. Glioblastoma Multiforme Treatment (GBM) Market: By Treatment, 2023-2033, USD (Million)
8.3. Glioblastoma Multiforme Treatment (GBM) Market: By End-user, 2023-2033, USD (Million)
8.4.Glioblastoma Multiforme Treatment (GBM) Market: By Region, 2023-2033, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Glioblastoma Multiforme Treatment (GBM) Market: By Treatment, 2023-2033, USD (Million)
8.4.1.1.2. Glioblastoma Multiforme Treatment (GBM) Market: By End-user, 2023-2033, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Glioblastoma Multiforme Treatment (GBM) Market: By Treatment, 2023-2033, USD (Million)
8.4.1.2.2. Glioblastoma Multiforme Treatment (GBM) Market: By End-user, 2023-2033, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Glioblastoma Multiforme Treatment (GBM) Market: By Treatment, 2023-2033, USD (Million)
8.4.1.3.2. Glioblastoma Multiforme Treatment (GBM) Market: By End-user, 2023-2033, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Glioblastoma Multiforme Treatment (GBM) Market: By Treatment, 2023-2033, USD (Million)
8.4.1.4.2. Glioblastoma Multiforme Treatment (GBM) Market: By End-user, 2023-2033, USD (Million)
8.4.1.5. France
8.4.1.5.1. Glioblastoma Multiforme Treatment (GBM) Market: By Treatment, 2023-2033, USD (Million)
8.4.1.5.2. Glioblastoma Multiforme Treatment (GBM) Market: By End-user, 2023-2033, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Glioblastoma Multiforme Treatment (GBM) Market: By Treatment, 2023-2033, USD (Million)
8.4.1.6.2. Glioblastoma Multiforme Treatment (GBM) Market: By End-user, 2023-2033, USD (Million)

9. Asia Pacific Glioblastoma Multiforme Treatment (GBM) Market, 2023-2033, USD (Million)
9.1. Market Overview
9.2. Glioblastoma Multiforme Treatment (GBM) Market: By Treatment, 2023-2033, USD (Million)
9.3. Glioblastoma Multiforme Treatment (GBM) Market: By End-user, 2023-2033, USD (Million)
9.4.Glioblastoma Multiforme Treatment (GBM) Market: By Region, 2023-2033, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Glioblastoma Multiforme Treatment (GBM) Market: By Treatment, 2023-2033, USD (Million)
9.4.1.1.2. Glioblastoma Multiforme Treatment (GBM) Market: By End-user, 2023-2033, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Glioblastoma Multiforme Treatment (GBM) Market: By Treatment, 2023-2033, USD (Million)
9.4.1.2.2. Glioblastoma Multiforme Treatment (GBM) Market: By End-user, 2023-2033, USD (Million)
9.4.1.3. India
9.4.1.3.1. Glioblastoma Multiforme Treatment (GBM) Market: By Treatment, 2023-2033, USD (Million)
9.4.1.3.2. Glioblastoma Multiforme Treatment (GBM) Market: By End-user, 2023-2033, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Glioblastoma Multiforme Treatment (GBM) Market: By Treatment, 2023-2033, USD (Million)
9.4.1.4.2. Glioblastoma Multiforme Treatment (GBM) Market: By End-user, 2023-2033, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Glioblastoma Multiforme Treatment (GBM) Market: By Treatment, 2023-2033, USD (Million)
9.4.1.5.2. Glioblastoma Multiforme Treatment (GBM) Market: By End-user, 2023-2033, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Glioblastoma Multiforme Treatment (GBM) Market: By Treatment, 2023-2033, USD (Million)
9.4.1.6.2. Glioblastoma Multiforme Treatment (GBM) Market: By End-user, 2023-2033, USD (Million)

10. Latin America Glioblastoma Multiforme Treatment (GBM) Market, 2023-2033, USD (Million)
10.1. Market Overview
10.2. Glioblastoma Multiforme Treatment (GBM) Market: By Treatment, 2023-2033, USD (Million)
10.3. Glioblastoma Multiforme Treatment (GBM) Market: By End-user, 2023-2033, USD (Million)
10.4.Glioblastoma Multiforme Treatment (GBM) Market: By Region, 2023-2033, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Glioblastoma Multiforme Treatment (GBM) Market: By Treatment, 2023-2033, USD (Million)
10.4.1.1.2. Glioblastoma Multiforme Treatment (GBM) Market: By End-user, 2023-2033, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Glioblastoma Multiforme Treatment (GBM) Market: By Treatment, 2023-2033, USD (Million)
10.4.1.2.2. Glioblastoma Multiforme Treatment (GBM) Market: By End-user, 2023-2033, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Glioblastoma Multiforme Treatment (GBM) Market: By Treatment, 2023-2033, USD (Million)
10.4.1.3.2. Glioblastoma Multiforme Treatment (GBM) Market: By End-user, 2023-2033, USD (Million)

11. Middle East and Africa Glioblastoma Multiforme Treatment (GBM) Market, 2023-2033, USD (Million)
11.1. Market Overview
11.2. Glioblastoma Multiforme Treatment (GBM) Market: By Treatment, 2023-2033, USD (Million)
11.3. Glioblastoma Multiforme Treatment (GBM) Market: By End-user, 2023-2033, USD (Million)
11.4.Glioblastoma Multiforme Treatment (GBM) Market: By Region, 2023-2033, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Glioblastoma Multiforme Treatment (GBM) Market: By Treatment, 2023-2033, USD (Million)
11.4.1.1.2. Glioblastoma Multiforme Treatment (GBM) Market: By End-user, 2023-2033, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Glioblastoma Multiforme Treatment (GBM) Market: By Treatment, 2023-2033, USD (Million)
11.4.1.2.2. Glioblastoma Multiforme Treatment (GBM) Market: By End-user, 2023-2033, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Glioblastoma Multiforme Treatment (GBM) Market: By Treatment, 2023-2033, USD (Million)
11.4.1.3.2. Glioblastoma Multiforme Treatment (GBM) Market: By End-user, 2023-2033, USD (Million)

12. Company Profile
12.1. Merck & Co., Inc. (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
12.2. Amgen, Inc.
12.3. F. Hoffmann-La Roche Ltd.
12.4. Pfizer Inc.
12.5. Amgen, Inc.
12.6. Teva Pharmaceutical Industries Ltd.
12.7. Sun Pharmaceutical Industries Ltd.
12.8. Arbor Pharmaceuticals, LLC
12.9. Amneal Pharmaceuticals
12.10. Karyopharm Therapeutics, Inc.
12.11. Other prominent players